1
|
Kulkarni MJ, Korwar AM, Mary S, Bhonsle HS, Giri AP. Glycated proteome: from reaction to intervention. Proteomics Clin Appl 2014. [PMID: 23184864 DOI: 10.1002/prca.201200101] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Glycation, a nonenzymatic reaction between reducing sugars and proteins, is a proteome wide phenomenon, predominantly observed in diabetes due to hyperglycemia. Glycated proteome of plasma, kidney, lens, and brain are implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative diseases, cancer, and aging. This review discusses the strategies to characterize protein glycation, its functional implications in different diseases, and intervention strategies to protect the deleterious effects of protein glycation.
Collapse
Affiliation(s)
- Mahesh J Kulkarni
- Proteomics Facility, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India.
| | | | | | | | | |
Collapse
|
2
|
Yu SL, An YJ, Yang HJ, Kang MS, Kim HY, Wen H, Jin X, Kwon HN, Min KJ, Lee SK, Park S. Alanine-Metabolizing Enzyme Alt1 Is Critical in Determining Yeast Life Span, As Revealed by Combined Metabolomic and Genetic Studies. J Proteome Res 2013; 12:1619-27. [DOI: 10.1021/pr300979r] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Sung-Lim Yu
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Yong Jin An
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Hey-ji Yang
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Mi-Sun Kang
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Ho-Yeol Kim
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - He Wen
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Xing Jin
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Hyuk Nam Kwon
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Kyung-Jin Min
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Sung-Keun Lee
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| | - Sunghyouk Park
- Inha
Research Institute for Medical Sciences, ‡Department of Biochemistry, and §Department of
Pharmacology, Center for Advanced Medical Education by
BK21 project, College of Medicine and ∥Department of Biological Sciences, Inha University, Incheon, Korea, 400-712
- College
of Pharmacy and #Natural Product Research Institute, Seoul National University, San 56-1 Sillim-dong, Gwanak-gu,
Seoul, Korea, 151-742
| |
Collapse
|
4
|
Abstract
GAPDH interacts with a plethora of diverse cellular proteins. The network of interacting partners, or interactome, is presented for GAPDH with the interacting molecules grouped into specific functional and structural categories. By organizing the binding partners in this way, certain common structural features are beginning to surface, such as acidic dipeptide sequences that are found in several of these binding proteins. Additionally, the consensus sequences for target polynucleotides are being brought to light. The categories, which are presented according to function, offer an opportunity for research into the corresponding structural correlates to these interactions. Recent discoveries of interacting proteins have revealed novel relationships that are generating emerging mechanisms. Proteins that are associated with age-related neurodegenerative diseases appear to be particularly prone to binding GAPDH, suggesting that GAPDH may be playing a role in these diseases. Neurodegenerative diseases that are discussed are the conformational diseases of aging, suggesting that GAPDH may be a global sensor for cellular conformational stress. In addition to GAPDH's oxidoreductase activity, several other enzymatic functions have been discovered, including peroxidase, nitrosylase, mono-ADP-ribosylase and kinase activities.
Collapse
Affiliation(s)
- Norbert W Seidler
- Department of Biochemistry, Kansas City University of Medicine and Biosciences, Kansas City, MO, USA
| |
Collapse
|
7
|
Hobart LJ, Seibel I, Yeargans GS, Seidler NW. Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 2004; 75:1379-89. [PMID: 15234195 DOI: 10.1016/j.lfs.2004.05.002] [Citation(s) in RCA: 92] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2003] [Accepted: 03/05/2004] [Indexed: 11/25/2022]
Abstract
Carnosine, a histidine-containing dipeptide, is a potential treatment for Alzheimer's disease. There is evidence that carnosine prevents oxidation and glycation, both of which contribute to the crosslinking of proteins; and protein crosslinking promotes beta-amyloid plaque formation. It was previously shown that carnosine has anti-crosslinking activity, but it is not known which of the chemical constituents are responsible. We tested the individual amino acids in carnosine (beta-alanine, histidine) as well as modified forms of histidine (alpha-acetyl-histidine, 1-methyl-histidine) and methylated carnosine (anserine) using glycation-induced crosslinking of cytosolic aspartate aminotransferase as our model. beta-Alanine showed anti-crosslinking activity but less than that of carnosine, suggesting that the beta-amino group is required in preventing protein crosslinking. Interestingly, histidine, which has both alpha-amino and imidazolium groups, was more effective than carnosine. Acetylation of histidine's alpha-amino group or methylation of its imidazolium group abolished anti-crosslinking activity. Furthermore, methylation of carnosine's imidazolium group decreased its anti-crosslinking activity. The results suggest that histidine is the representative structure for an anti-crosslinking agent, containing the necessary functional groups for optimal protection against crosslinking agents. We propose that the imidazolium group of histidine or carnosine may stabilize adducts formed at the primary amino group.
Collapse
Affiliation(s)
- Laura J Hobart
- Department of Biochemistry, University of Health Sciences, 1750 Independence Avenue, Kansas City, MO 64106-1453, USA
| | | | | | | |
Collapse
|
8
|
Seidler NW, Yeargans GS, Morgan TG. Carnosine disaggregates glycated alpha-crystallin: an in vitro study. Arch Biochem Biophys 2004; 427:110-5. [PMID: 15178493 DOI: 10.1016/j.abb.2004.04.024] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2004] [Revised: 04/27/2004] [Indexed: 11/19/2022]
Abstract
Protein glycation, which promotes aggregation, involves the unwanted reaction of carbohydrate oxidation products with proteins. Glycation of lens alpha-crystallin occurs in vivo and may contribute to cataractogenesis. Anti-glycation compounds such as carnosine may be preventive, but interestingly carnosine reverses lens opacity in human trials. The mechanism for this observation may involve carnosine's ability to disaggregate glycated protein. We investigated this hypothesis using glycated alpha-crystallin as our in vitro model. Methylglyoxal-induced glycation of alpha-crystallin caused aggregation as evidenced by increased 90 degrees light scattering. After addition of carnosine, light scattering returned to baseline levels suggesting that the size of the glycation-induced aggregates decreased. Additionally, carnosine decreased tryptophan fluorescence polarization of glycated alpha-crystallin, suggesting that carnosine increased peptide chain mobility, which may contribute to the controlled unfolding of glycated protein. Comparatively, guanidine-HCl and urea had no effect. Our data support the hypothesis that carnosine disaggregates glycated alpha-crystallin.
Collapse
Affiliation(s)
- Norbert W Seidler
- University of Health Sciences, Department of Biochemistry, 1750 Independence Avenue, Kansas City, MO 64106-1453, USA.
| | | | | |
Collapse
|
10
|
Naito Z, Takashi E, Xu G, Ishiwata T, Teduka K, Yokoyama M, Yamada N, Sugisaki Y, Asano G. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol 2003; 74:23-32. [PMID: 12645629 DOI: 10.1016/s0014-4800(03)80005-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Extracellular signal-regulated kinase (ERK) 1/2 is an important intracellular proteinase associated with myocardial protection against heart injury. Hyperglycemia was also reported to be highly involved in heart injury by the formation of advanced glycation end products (AGEs) in myocardial protein, resulting in its altered structure and function. However, the effect of this glycation on mitogen-activated protein kinases, particularly ERK1/2, in the myocardium is largely unclarified. In this study, we investigated whether the glycation of an intracellular protein, ERK1/2, would result in ERK1/2-AGEs formation that adversely affects ERK1/2 activation in the rat heart under hyperglycemia. Hyperglycemia was induced by injection of streptozotocin (STZ) and hearts were examined 4 and 20 weeks after STZ treatment. By immunohistochemical staining and Western blotting, it was determined that the level of phosphorylated ERK1/2 in the rat heart under hyperglycemia 20 weeks after STZ treatment decreased markedly by about 50% of that of the time-matched control group, whereas in the case of 4 weeks after STZ treatment, it increased by about 2.7-fold that of the time-matched group. The level of deposition of AGEs in proteins of the myocardium increased significantly depending on the duration of hyperglycemia. Twenty weeks after STZ treatment, two clear bands corresponding to 44- and 42-kDa AGEs were detected by Western blotting: these corresponded to protein sizes of ERK1/2. The immunoprecipitation method further confirmed the formation and the increased intensity of ERK1/2-AGEs in the rat heart under hyperglycemia for 20 weeks. These results demonstrate that long-term hyperglycemia may inhibit ERK1/2 phosphorylation in the myocardium, whereas a short-term (4 weeks) hyperglycemia enhances its phosphorylation. The ERK1/2 phosphorylation under long-term hyperglycemia is very different from that under short-term hyperglycemia. In addition, this inhibition of ERK1/2 activation appears to be dependent on the formation of ERK1/2-AGEs under long-term hyperglycemia, which may be related in part to the etiology of diabetic cardiomyopathy. It also suggests that the formation of AGEs in intracellular enzymes and proteins under hyperglycemia could play important roles in the development of diabetes complications.
Collapse
Affiliation(s)
- Zenya Naito
- Department of Pathology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-0022, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|